{"key":"thymosin-alpha-1","slug":"thymosin-alpha-1","name":"Thymosin Alpha-1","other_names":[],"kind":"single","area":{"slug":"immune","name":"Immune"},"classification":"Thymic peptide (thymalfasin)","standing":{"id":"approved","label":"Licensed medicine","rank":5},"summary":"A 28 amino acid peptide first isolated from the thymus. As thymalfasin it is licensed in a number of countries, mainly for hepatitis B and as an immune adjuvant, and is not licensed in the United States.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":624,"in_humans":375,"clinical_trials":56},"retired":false,"updated_at":"2026-11-19T00:17:24.814Z","url":"https://pepts.wiki/compounds/thymosin-alpha-1","article":null,"evidence":{"query":"(\"thymosin alpha 1\"[tiab] OR \"thymosin alpha-1\"[tiab] OR thymalfasin[tiab])","fetched_at":"2026-11-16T23:08:52.426Z","counts":{"rcts":39,"human":375,"total":624,"reviews":86,"clinicalTrials":56},"years":[{"year":2012,"count":7},{"year":2013,"count":7},{"year":2014,"count":1},{"year":2015,"count":12},{"year":2016,"count":4},{"year":2017,"count":10},{"year":2018,"count":16},{"year":2019,"count":13},{"year":2020,"count":19},{"year":2021,"count":13},{"year":2022,"count":8},{"year":2023,"count":19},{"year":2024,"count":13},{"year":2025,"count":9},{"year":2026,"count":15}],"top":[{"doi":"10.1007/s10787-023-01354-2","url":"https://pubmed.ncbi.nlm.nih.gov/37845598/","kind":"meta","pmid":"37845598","year":2023,"title":"The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression","venue":"Inflammopharmacology","authors":"Soeroto AY, Suryadinata H, Yanto TA, et al."},{"doi":"10.29271/jcpsp.2024.12.1497","url":"https://pubmed.ncbi.nlm.nih.gov/39648386/","kind":"meta","pmid":"39648386","year":2024,"title":"Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis","venue":"Journal of the College of Physicians and Surgeons--Pakistan : JCPSP","authors":"Cao A, Feng F, Zhou X"},{"doi":"10.1007/s00134-022-06745-7","url":"https://pubmed.ncbi.nlm.nih.gov/35713670/","kind":"rct","pmid":"35713670","year":2022,"title":"Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial","venue":"Intensive care medicine","authors":"Ke L, Zhou J, Mao W, et al."},{"doi":"10.1186/s12876-020-01477-8","url":"https://pubmed.ncbi.nlm.nih.gov/33076834/","kind":"meta","pmid":"33076834","year":2020,"title":"The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis","venue":"BMC gastroenterology","authors":"Peng D, Xing HY, Li C, et al."},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/38308608/","kind":"review","pmid":"38308608","year":2024,"title":"Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials","venue":"Alternative therapies in health and medicine","authors":"Dinetz E, Lee E"},{"doi":"10.1002/14651858.CD009004.pub2","url":"https://pubmed.ncbi.nlm.nih.gov/23633363/","kind":"meta","pmid":"23633363","year":2013,"title":"Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection","venue":"The Cochrane database of systematic reviews","authors":"Xia Y, Luo H, Liu JP, et al."},{"doi":"10.1093/ajhp/58.10.886","url":"https://pubmed.ncbi.nlm.nih.gov/11381492/","kind":"review","pmid":"11381492","year":2001,"title":"Thymosin alpha-1","venue":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","authors":"Ancell CD, Phipps J, Young L"},{"doi":"10.3390/ijms262311470","url":"https://pubmed.ncbi.nlm.nih.gov/41373628/","kind":"review","pmid":"41373628","year":2025,"title":"Aging and Thymosin Alpha-1","venue":"International journal of molecular sciences","authors":"Simonova MA, Ivanov I, Shoshina NS, et al."},{"doi":"10.1093/ofid/ofaa588","url":"https://pubmed.ncbi.nlm.nih.gov/33506065/","kind":"study","pmid":"33506065","year":2021,"title":"Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients","venue":"Open forum infectious diseases","authors":"Matteucci C, Minutolo A, Balestrieri E, et al."},{"doi":"10.1080/14712598.2018.1484104","url":"https://pubmed.ncbi.nlm.nih.gov/30063866/","kind":"review","pmid":"30063866","year":2018,"title":"Thymosin alpha 1 treatment for patients with sepsis","venue":"Expert opinion on biological therapy","authors":"Pei F, Guan X, Wu J"}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}